Global Antibacterial Drugs Market
Overview:
Antibacterial drugs play an important role in advanced healthcare, as they are widely used to treat and prevent infectious diseases. These drugs are derived from mold or bacteria, and slow down or destroy bacteria growth. Antibacterial drugs are also used to treat urinary infections caused by Streptococcus pyogenes, S. aureus, E. coli, and other bacterial infections.
Drivers:
High prevalence or incidence of urinary tract infections across the globe is expected to drive the global antibacterial drugs market growth. For instance, according to the study published in February 2019, โPrevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Ugandaโ, the prevalence of urinary tract infections was 32.2% among the study.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/177
Restraints:
High prevalence or incidence of antibiotic-resistant infections is expected to hinder growth of the global antibacterial drugs market over the forecast period. For instance, as reported by the Center for Disease Control and Prevention (CDC), more than 2.8 million antibiotic-resistant infections occur each year in the United States.
Opportunities:
The availability of open-access database of antibiotics is expected to provide significant growth opportunities for the players in market.
Key Takeaways:
Increasing prevalence of bacterial infections and the availability of cheap generic antibacterial drugs are some major factors expected to aid in the growth of the market.
Market Trends:
Several antibacterial drugs in the pipeline. For instance, as per the World Health Organization (WHO), there are 10 biologicals and 50 antibiotics and combinations in the clinical pipeline as of September 2019 for the treatment of WHO priority pathogens, tuberculosis, and C. difficile infections.
๐๐จ ๐๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐๐ซ๐ @ https://www.coherentmarketinsights.com/insight/request-pdf/177
Competitive Landscape:
Key Players active in the global antibacterial drugs market are Sanofi, Pfizer, Inc., Novartis AG, Merck & Co., Inc., Johnson & Johnson, Forest Laboratories, Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Bayer AG, AstraZeneca plc, GlaxoSmithKline plc, Spero Therapeutics, VenatoRx Pharmaceuticals, Inc., TenNor Therapeutics, NacuGen Therapeutics Inc., Sichuan Pharmaceutical Co., Ltd., Boston Pharmaceuticals Inc., Debiopharm Group, Micurx Pharmaceutical Inc., Melinta Therapeutics, Entasis Therapeutics, R-Pharm Group, Iterum Therapeutics plc, Shionogi Inc, and Theravance Biopharma, Inc.
Key Developments:
In September 2019, the Global Antibiotic Research and Development Partnership (GARDP) and Entasis Therapeutics announced the initiation of a phase 3 pivotal trial of zoliflodacin, an oral antibiotic to treat uncomplicated gonorrhea.
In August 2019, Venatorx Pharmaceuticals announced that it has initiated enrollment in its Phase 3 trial of cefepime/VNRX-5133 in patients with complicated urinary tract infections.
๐๐ถ๐ฟ๐ฒ๐ฐ๐ ๐ฃ๐๐ฟ๐ฐ๐ต๐ฎ๐๐ฒ ๐ง๐ต๐ถ๐ ๐ฅ๐ฒ๐ฝ๐ผ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐๐ฒ๐ ๐๐น๐ฎ๐ ๐จ๐ฆ๐ ๐ฎ๐ฌ๐ฌ๐ฌ ๐ข๐๐
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/177
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Technological Advancement
- Regulatory Scenario
- Pipeline Analysis
- Market Dynamics
- Global Antibacterial Drugs Market, By Drug Class, 2017 โ 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019โ2027
- Segment Trends
- ฮฒ-lactams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Quinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Macrolides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Tetracyclines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Aminoglycosides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Sulfonamides
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Phenicols
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Antibacterial Drugs Market, By Distribution Channel, 2017 โ 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2019โ2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 โ 2027, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/antibacterial-drugs-market-to-surpass-us-497-billion-by-2026-134
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837